rs116414807

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_138694.4(PKHD1):​c.391-43T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00183 in 1,451,414 control chromosomes in the GnomAD database, including 42 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0086 ( 26 hom., cov: 33)
Exomes 𝑓: 0.0010 ( 16 hom. )

Consequence

PKHD1
NM_138694.4 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.267

Publications

1 publications found
Variant links:
Genes affected
PKHD1 (HGNC:9016): (PKHD1 ciliary IPT domain containing fibrocystin/polyductin) The protein encoded by this gene is predicted to have a single transmembrane (TM)-spanning domain and multiple copies of an immunoglobulin-like plexin-transcription-factor domain. Alternative splicing results in two transcript variants encoding different isoforms. Other alternatively spliced transcripts have been described, but the full length sequences have not been determined. Several of these transcripts are predicted to encode truncated products which lack the TM and may be secreted. Mutations in this gene cause autosomal recessive polycystic kidney disease, also known as polycystic kidney and hepatic disease-1. [provided by RefSeq, Jul 2008]
PKHD1 Gene-Disease associations (from GenCC):
  • autosomal recessive polycystic kidney disease
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Myriad Women’s Health, Orphanet
  • polycystic kidney disease 4
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Laboratory for Molecular Medicine, Genomics England PanelApp
  • Caroli disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 6-52076376-A-T is Benign according to our data. Variant chr6-52076376-A-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 262402.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00859 (1309/152354) while in subpopulation AFR AF = 0.0288 (1197/41574). AF 95% confidence interval is 0.0274. There are 26 homozygotes in GnomAd4. There are 572 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 26 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_138694.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PKHD1
NM_138694.4
MANE Select
c.391-43T>A
intron
N/ANP_619639.3
PKHD1
NM_170724.3
c.391-43T>A
intron
N/ANP_733842.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PKHD1
ENST00000371117.8
TSL:1 MANE Select
c.391-43T>A
intron
N/AENSP00000360158.3
PKHD1
ENST00000340994.4
TSL:5
c.391-43T>A
intron
N/AENSP00000341097.4

Frequencies

GnomAD3 genomes
AF:
0.00861
AC:
1310
AN:
152236
Hom.:
26
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0289
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00517
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.000162
Gnomad OTH
AF:
0.00812
GnomAD2 exomes
AF:
0.00241
AC:
603
AN:
250190
AF XY:
0.00173
show subpopulations
Gnomad AFR exome
AF:
0.0285
Gnomad AMR exome
AF:
0.00255
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000929
Gnomad NFE exome
AF:
0.000336
Gnomad OTH exome
AF:
0.00197
GnomAD4 exome
AF:
0.00103
AC:
1340
AN:
1299060
Hom.:
16
Cov.:
20
AF XY:
0.000922
AC XY:
604
AN XY:
655214
show subpopulations
African (AFR)
AF:
0.0270
AC:
816
AN:
30226
American (AMR)
AF:
0.00315
AC:
140
AN:
44494
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25154
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38890
South Asian (SAS)
AF:
0.0000241
AC:
2
AN:
82940
European-Finnish (FIN)
AF:
0.0000563
AC:
3
AN:
53248
Middle Eastern (MID)
AF:
0.00587
AC:
32
AN:
5456
European-Non Finnish (NFE)
AF:
0.000233
AC:
225
AN:
963784
Other (OTH)
AF:
0.00222
AC:
122
AN:
54868
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
70
140
210
280
350
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00859
AC:
1309
AN:
152354
Hom.:
26
Cov.:
33
AF XY:
0.00768
AC XY:
572
AN XY:
74502
show subpopulations
African (AFR)
AF:
0.0288
AC:
1197
AN:
41574
American (AMR)
AF:
0.00516
AC:
79
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.000162
AC:
11
AN:
68034
Other (OTH)
AF:
0.00803
AC:
17
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
66
133
199
266
332
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00423
Hom.:
0
Bravo
AF:
0.00983
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 01, 2017
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:2
Nov 12, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Autosomal recessive polycystic kidney disease Benign:1
Apr 13, 2018
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.96
DANN
Benign
0.59
PhyloP100
-0.27
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs116414807; hg19: chr6-51941174; API